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Recent studies (1-3) of polyclonally stimulated human peripheral blood lym- 
phocytes have suggested that, after initial activation of the T  cell, interleukin 2 
(IL-2) may be necessary for optimal cell surface expression of the IL-2 receptor 
(IL-2-R).  However,  since these  studies examined heterogenous populations of 
cells, it was not possible to determine whether the apparent upregulation of IL- 
2-R expression by IL-2 was the result of occupancy of the receptor by its ligand, 
or whether it reflected a  more complex event that required the interaction of 
several cell types. In the current study, we have used a  murine, untransformed, 
antigen-specific, class II-restricted T  cell clone to analyze the effects of exoge- 
nous IL-2, as well as antigen, on the cell surface expression of the IL-2-R, and 
on the level of IL-2-R cytoplasmic messenger RNA (mRNA). 
Materials and Methods 
Animals.  B 10.A/SgSn (B I 0.A) mice were obtained from Harlan Sprague Dawley Inc. 
(Madison, WI). 
Medium.  Culture medium consisted ofa 1:1 (vol/vol) mixture of RPMI 1640 (Biofluids, 
Inc., Rockville,  MD) and Eagle's Hank's amino acid medium. This mixture was supple- 
mented with  10%  fetal calf serum,  4 mM glutamine,  100  U  penicillin,  and 50 ~M 2- 
mercaptoethanoi. 
Monoclonal Antibodies.  Monoclonal antibodies specific  for IL-2-R, (7D4)  (4); L3T4, 
(GK1.5) (5); Thy-1, (JIJ) (6); and rat ~ light chains (MAR 18.5) (7) have been previously 
described. Anti-Thy-l.2 was purchased from New England Nuclear (Boston, MA). 
Cell Culture.  The production and growth characteristics of the poly-(L-glutamic acid  s°- 
30  10  L-alanine  -L-tyrosine  )n (GAT)-specific,  B10.A-derived, helper T  cell clone,  11.4,  have 
been described previously (8). This cell line was maintained by passage every 3-4 d in 
medium supplemented with unfractionated rat spleen supernatant fluid containing ~20 
U/ml IL-2. For experimental cultures, 11.4 T cells (0.5-1.0 ×  106) were incubated in 24- 
well, flat-bottomed plates (3524; Costar Data Packaging Corp., Cambridge, MA) contain- 
ing 1 ml of medium with various concentrations of GAT (Vega Biotechnologies, Inc., 
Tucson,  AZ) and  antigen-presenting cells  (5  ×  10 6)  (APC)  or  IL-2.  The  APC  were 
irradiated (3,300 rad), anti-Thy-l.2 and complement-treated syngeneic spleen cells (8). 
The sources of IL-2 were either unfractionated murine IL-2-containing culture fluids (4) 
supplemented with  10  mg/ml of a-methylmannoside (Sigma  Chemical Co., St.  Louis, 
MO), affinity-purified human IL-2 (9) (kindley provided by R. Robb, E. I. DuPont Co., 
Glenolden,  PA),  or  recombinant human  IL-2  (10)  (kindly provided  by Cetus  Corp., 
Emeryville, CA). Cytofluormetric  analysis of the cultured cells was performed as previously 
described (4). 
Dot and Northern Blot Analysis.  Cytoplasmic RNA was isolated as previously described 
(11),  and  quantitated  by  spectrophotometric determination at  260  nm.  For  dot-blot 
analysis, the RNA was serial-diluted (twofold) with 15× SSC (standard sodium citrate; 1  × 
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SSC is 0.15 M NaC1 in 0.015 M sodium citrate), blotted on nitrocellulose with a suction 
manifold,  fixed  by baking  at 80°C  for  1 h, and hybridized  to nick-translated  insert, 
purified from either pcEXV-mIL2R8 (12) or TM8 (13). In other experiments,  unfrac- 
tionated RNA  was electrophoresed  on  1%  agarose-formaldehyde  gels, transferred to 
nitrocellulose, and then hybridized to nick-translated insert from pcEXV-mIL2R8. 
Results and Discussion 
The 11.4 T  cell clone is propagated in medium supplemented solely with IL- 
2 (i.e.  in the absence of APC and antigen) and always bears low but detectable 
levels of IL-2-R 3-4  d  after feeding with IL-2 (see  kinetic data below).  Since 
11.4 proliferates when challenged with either IL-2 or GAT and the appropriate 
APC (in  the absence of exogenous IL-2),  it was  possible  to directly study the 
effect of exogenous IL-2 and antigen stimulation on IL-2-R expression. Stimu- 
lation of 11.4  with either unfractionated murine IL-2-containing supernatants 
(Fig.  1), purified human IL-2 from the Jurkat cell line (Fig.  1), or recombinant 
human IL-2  (Fig.  2),  resulted in a  2-4-fold increase  in  IL-2-R expression, as 
judged by the change in the median fluorescent intensity. Since, at the start of 
culture, the cells bore levels of IL-2-R comparable to that detected 42  h  after 
culture in medium alone, the observed increase in IL-2-R could not simply be 
due  to  a  decay  in  IL-2-R  expression  on  unstimulated  11.4  cells  relative  to 
stimulated cells,  but reflect a true induction of cell surface receptor expression. 
Furthermore, unlike other IL-2-dependent T cells, such as CTLL or HT2, which 
rapidly die  when  cultured without IL-2,  the  majority of 11.4  survive a  42-h 
culture in the absence of IL-2 (always >90%  viable cells recovered) and retain 
the capacity to proliferate to exogenous IL-2 or GAT and APC (not shown). 
Thus,  IL-2  is at  least sufficient for the  induction of the  IL-2-R on  cells  that 
already bear levels of IL-2-R. We cannot, however, rule out the participation of 
other soluble products secreted by 11.4 in response to IL-2. 
Antigen stimulation of 11.4 resulted in a dose-dependent increase in IL-2-R 
expression (Fig.  1B).  GAT-stimulated 11.4  expressed two to four times more 
IL-2-R than  IL-2-stimulated  11.4.  Time course  studies (not shown) indicated 
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FIGURE  l.  IL-2-R expression of 11.4 T  cells,  l 1.4 T  cells were cultured with medium alone, 
mouse concanavalin A (Con A)-supernatant fluids (100 U/ml), purified human IL-2 (200 U/ 
m]), or GAT and B10.A APC, as indicated, for 42 h. Cytofluorometric profiles represent IL- 
2-R expression of the cultured cells analyzed by staining with fluorescein isothiocyanate (FITC)- 
7D4. The experiments shown in A and B were performed on different days. The staining was 
judged to  be specific by the capacity of unlabeled 7D4  to  inhibit the fluorescent signal of 
F1TC-TD4 to a level comparable to unstained cells (data not shown). MALEK  AND  ASHWELL  BRIEF  DEFINITIVE  REPORT  1577 
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FIGURE  2.  Effect of IL-2 on expression of cell surface antigens of 11.4.  11.4 T  cells were 
cultured in medium alone (---), or medium supplemented with 500 U/ml recombinant human 
IL-2 (--) for 42 h. The cells were incubated with the indicated antibody, washed, then stained 
with FITC-MAR18.5  followed by cytofluorometric analysis. The  negative control was cells 
stained with only FITC-MAR18.5. 
that  optimal  cell  surface  IL-2-R  levels were  seen  30  h  after  stimulation  with 
either  IL-2  or GAT,  and  by 72  h,  IL-2-R  expression  had  decreased  to  levels 
comparable to that shown for unstimulated  11.4 (Fig.  1, A and B). The basis for 
the ability of antigen  stimulation  to induce more cell-surface IL-2-R than  IL-2 
stimulation is not known. It is unlikely that the effect of antigen stimulation on 
IL-2-R  expression  can  be  due  simply  to  large amounts  of endogenous  IL-2 
production and subsequent IL-2  upregulation.  If this  were the case, we would 
expect  that  IL-2-R  induction  by IL-2  would precede  induction  stimulated  by 
antigen.  However, this was not observed in kinetic experiments. 
The  effect  of  IL-2  on  IL-2-R  expression  was  selective.  The  addition  of 
recombinant human  IL-2 caused no increase in L3T4, and it actually caused a 
decrease  in  Thy-1,  whereas  IL-2-R  increased  by more  than  twofold (Fig.  2). 
Therefore, it is unlikely that the increase observed for IL-2-R can be accounted 
for  simply by a  general  cell-cycle-dependent  fluctuation  in  expression  of cell 
surface proteins whose levels are maintained during the growth of 11.4. 
The increased level of surface IL-2-R after IL-2 stimulation could be due to 
increased synthesis of this protein, or could reflect other effects on IL-2-R, such 
as a decrease in turnover, or a redistribution of molecules already present in the 
cell. To distinguish between these possibilities, IL-2-R cytoplasmic mRNA from 
11.4  was quantitated  by dot-blot analysis,  using a  S2P-labeiled complementary 
DNA  probe  containing  the  entire  coding  region  of the  mouse  IL-2-R.  Cell 
equivalents were not compared when assessing the specific induction of mRNA, 
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1.5-2-fold more in the case of 11.4). Instead, we applied identical quantities (#g) 
of  RNA  from  each  group  to  the  nitrocellulose,  to  ensure  that  any  changes 
observed in  mRNA  levels were  specific increases,  not  simply the  result  of the 
different  percentage  of  cells  in  each  group  moving  through  the  cell  cycle. 
Stimulation  of  11.4  with  purified  human  IL-2  resulted  in  a  dose-dependent 
increase in IL-2-R mRNA (Fig.  3A), with maximum IL-2-R mRNA detected 7- 
24  h  after addition  of an  optimal dose of purified  human  IL-2 (an  increase  of 
about  eightfold)  (Fig.  3B).  In  another  experiment,  IL-2  stimulation  increased 
IL-2-R mRNA  -32-fold,  as  did  antigen  stimulation  (Fig.  3D),  whereas  Thy-1 
mRNA  increased  only twofold (Fig.  3 C).  Thus,  unlike  the changes detected  in 
cell surface IL-2-R (Fig.  1),  the dramatic increase in  IL-2 mRNA seen after IL- 
2  stimulation appeared to be comparable to that seen after antigen  stimulation. 
One possible cause of this dichotomy, an intracellular location for newly synthe- 
sized  protein,  is  currently  under  investigation.  The  significance  of the  small 
increase in  Thy-1  mRNA  is not clear.  It may reflect an increase in  synthesis to 
compensate for the decrease in cell surface expression of Thy-1  (Fig.  2),  or the 
necessity of dividing cells to produce those proteins that must be maintained  in 
the daughter cells.  In any case,  the  large increase  in  IL-2-R mRNA  after IL-2 
stimulation suggests that it was not due to a  generalized increase, within lympho- 
cytes preparing to divide, of cytoplasmic mRNA encoding surface antigens. 
Northern blot analyses confirmed that the poststimulation increase in hybrid- 
ization of the cDNA probe in the dot blots was in fact due to an increase in  IL- 
2-R  mRNA.  Each  of the  five mRNA  species that are characteristic  for  IL-2-R 
mRNA  (14)  was easily seen  in  11.4  cells after IL-2 stimulation,  and  each band 
was  substantially  increased  when  compared  to  RNA  from  unstimulated  11.4 
FIGURE 3.  Analysis  of RNA from 11.4 T  cells. Cytoplasmic RNA was isolated from 11.4 
cells after culture with the indicated amount of purified human IL-2 or GAT and APC. The 
first dot in blots (A-D) contained 2 vg of RNA, and the rest represent twofold serial dilutions. 
Northern blot analysis was performed on 5 Cg of cytoplasmic RNA. Ethidium bromide staining 
of the gel to visualize 28 S and  18 S ribosomal RNA confirmed  that each lane contained 
equivalent amounts of RNA, and that the RNA was not significantly degraded  (not shown). 
The cells in A and C-E were cultured  for 24 h. The RNA was hybridized with s2p-labelled 
probes, 1L-2-R8 (for the IL-2-R) and TM8 (for Thy-1), as indicated. Blots were washed with 
0.2x SSC containing 0.1% sodium dodecyl sulfate at 60°C.  Autoradiographs  were exposed 
for 72 h with an intensifying screen at -70°C, The blots shown in A-E represent  data from 
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cells. These results are consistent with transcriptional control of IL-2-R upregu- 
lation by antigen or IL-2. However, it is possible that increased cytoplasmic IL- 
2-R mRNA in  11.4 is the result of mRNA stabilization, rather than increased 
transcription.  Nuclear RNA runoff experiments must be performed to distin- 
guish between these possibilities. 
Our study extends the analysis of polyclonally-stimulated  human T  cells (1-3) 
by  demonstrating  that  the  induction  of the  IL-2-R  is  the  result  of  IL-2-R 
occupation  by  IL-2  on  a  single  cell  type.  We  do  not  know  whether  IL-2 
upregulation of the IL-2-R is a property of all IL-2-R-bearing T  cells. However, 
the results already reported for mitogen-activated human T  cells  (1-3) suggest 
that IL-2 regulation of IL-2-R is a property not solely expressed by long-term- 
cultured T  cells. 
The ability of IL-2 to upregulate its own receptor may have implications for 
in vivo immune response. The specificity of the induction, at both the mRNA 
and protein levels, suggests that the increased levels of IL-2-R play a role in the 
activation of immune T  cells.  One  might expect,  for example,  that  it would 
permit antigen-independent amplification of recently antigen-activated T  cells. 
However, such speculations must be  made cautiously, in view of the recently 
reported observation (3) that IL-2 induces only low-affinity IL-2-R on mitogen- 
activated human peripheral blood lymphocytes. Whether this is also the case for 
antigen-specific T  cells remains to be determined. Thus, the potential immuno- 
regulatory role of IL-2 upregulation of the IL-2-R will require further investi- 
gation. 
Summary 
Stimulation of a class II-restricted, antigen-specific T  cell clone with interleu- 
kin 2  (IL-2) resulted in substantial increases in both cell surface IL-2 receptor 
(IL-2-R) and cytoplasmic IL-2-R messenger RNA (mRNA), whereas no increase 
was observed for cell-surface expression of Thy-1 and L3T4 antigens, and only 
a  modest increase in Thy-1  mRNA was observed. These experiments demon- 
strate that, after initial acquisition of the IL-2-R, IL-2 as well as antigen is able 
to directly upregulate both the level of IL-2-R mRNA and cell surface IL-2-R 
molecules. 
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